+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneus Ltd - logo

Founded in 2007, Regeneus are a Sydney-based regenerative medicine company developing a portfolio of innovative cell-based therapies, with a focus on osteoarthritis and musculoskeletal disorders, as well as oncology and dermatology diseases. The company's portfolio of therapeutic products is being developed using stem cell and immune oncology technology platforms.The company has two product candidates in Phase 1 trials for humans, Progenza and RGSH4K. Regeneus is headquartered in New South Wales, Australia.

From
Global Cell Therapy Biomanufacturing Market 2024-2029 - Product Thumbnail Image

Global Cell Therapy Biomanufacturing Market 2024-2029

  • Report
  • August 2024
  • 112 Pages
  • Global
From
Stem Cell Collaboration and Licensing Deals 2010-2024 - Product Thumbnail Image

Stem Cell Collaboration and Licensing Deals 2010-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
From
From
From
From
From
From
Lichen Planus- Pipeline Insight, 2025 - Product Thumbnail Image

Lichen Planus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2025 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator